의과대학 - 의과대학

  • 부교수
  • 이세경

학술지 논문

  • (2024)  Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients' Returning to Work (START): A Multi-center, Randomized Controlled Trial.  CANCER RESEARCH AND TREATMENT.  15,  5
  • (2023)  Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer.  BREAST.  72, 
  • (2023)  Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast Cancer.  JOURNAL OF BREAST CANCER.  26,  6
  • (2023)  The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis.  CANCERS.  15,  22
  • (2023)  Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy.  WORLD JOURNAL OF CLINICAL CASES.  11,  27
  • (2023)  Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis.  JMIR PUBLIC HEALTH AND SURVEILLANCE.  9,  1
  • (2023)  Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study.  ANNALS OF SURGICAL TREATMENT AND RESEARCH.  105,  1
  • (2023)  Breast Cancer Statistics in Korea, 2019.  JOURNAL OF BREAST CANCER.  26,  3
  • (2023)  Epidemiology of Second Non-breast Primary Cancers among Survivors of Breast Cancer: A Korean Population-Based Study by the SMARTSHIP Group.  CANCER RESEARCH AND TREATMENT.  55,  2
  • (2023)  Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level.  JOURNAL OF BREAST CANCER.  26,  2
  • (2023)  The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial.  FRONTIERS IN ONCOLOGY.  13, 
  • (2023)  Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis.  CANCERS.  15,  5
  • (2023)  Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?.  ANNALS OF SURGICAL ONCOLOGY.  30,  2
  • (2023)  Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study.  THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY.  15, 
  • (2022)  Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?.  ANNALS OF SURGICAL ONCOLOGY.  30,  2
  • (2022)  Characteristics and chronologically changing patterns of late-onset breast cancer in Korean women of age >= 70 years: A hospital based-registry study.  BMC CANCER.  22,  1
  • (2022)  Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors.  CANCER RESEARCH AND TREATMENT. 
  • (2022)  Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay.  JOURNAL OF BREAST CANCER.  25,  6
  • (2022)  Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients' Returning to Work (START): A Multi-center, Randomized Controlled Trial.  CANCER RESEARCH AND TREATMENT. 
  • (2022)  Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?.  JOURNAL OF CLINICAL MEDICINE.  11,  21

학술회의논문

  • (2022)  Breast Cancer in Korea.  UNIVERSITY OF HAWAII( Women's Cancer Focus Group meeting).  미국
  • (2019)  Epidermal growth factor receptor as therapeutic target in hormone receptor-positive breast cancer.  SABCS.  미국
  • (2019)  Impact of chemotherapy and radiotherapy on tissue expander or implant removal in the patients who received mastectomy and immediate breast reconstruction.  SABCS.  미국
  • (2019)  Risk of ipsilateral breast tumor recurrence in ductal carcinoma in situ following breast conserving surgery.  SABCS.  미국
  • (2019)  The clinical significance of EGFR(+) and HER2(+) breast cancer and interaction with tumor associated macrophages.  SABCS.  미국
  • (2019)  Low estrogen receptor positive (1-10%) breast cancer prevalence, treatment patterns and prognosis: A single institution’s experience in Korea.  SABCS.  미국
  • (2019)  Protein-protein interaction of HER2 predicts the prognosis of hormone receptor-positive HER2-negative breast cancer.  SABCS.  미국
  • (2019)  Radiologic complete response after neoadjuvant chemotherapy in advanced breast cancer can predict survival outcome, but not pathologic complete response.  SABCS.  미국
  • (2019)  The 5-years conditional disease free survival and overall survival for breast cancer patients in Korea.  SABCS.  미국
  • (2019)  Profiling protein-protein interactions at single-molecule level as a novel biomarker-driven screening method for the detection of tumor recurrence in breast cancer patients.  SABCS.  일본
  • (2019)  Serum protein expression predicts neoadjuvant chemotherapy response in patients with locally advanced breast cancer.  SABCS.  미국
  • (2019)  Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?.  유방암학회추계학술대회.  대한민국
  • (2019)  A MULTI-CENTER, OPEN-LABEL, PARALLEL, PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LUMINOMARKTM (INDOCYANINE GREEN 0.01MG +HYALURONIC ACID SODIUM 4MG/2ML) FOR CALIZATION IN PATIENTS.  GBCC.  대한민국
  • (2019)  A NEW DEVELOPED PREDICTED PROGNOSTIC SCORE (GENESWELLTM BCT) AS A PREDICTOR OF RISK OF RECURRENCE IN HR+/HER2- EARLY BREAST CANCER IRRESPECTIVE OF AGE.  GBCC.  대한민국
  • (2019)  A PREDICTIVE MODEL FOR PATHOLOGIC COMPLETE RESPONSE IN BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY USING MACHINE LEARNING.  GBCC.  대한민국
  • (2019)  BASAL AND IL-1β-INDUCED IL-8 IS SUPPRESSED BY CELASTROL IN TRIPLE NEGATIVE BREAST CANCER.  GBCC.  대한민국
  • (2019)  CCL2 DERIVED FROM EGFR AND HER2(+) BREAST CANCER CELLS RECRUITS TUMOR ASSOCIATED MACROPHAGES.  GBCC.  대한민국
  • (2019)  EFFECT OF POLOXAMER-BASED THERMO-SENSITIVE SOL-GEL ON SHOULDER MOTION AFTER AXILLARY LYMPH NODE DISSECTION IN PATIENTS WITH BREAST CANCER: A MULTI-CENTER DOUBLE-BLIND, RANDOMIZED CONTROLLED TRIAL.  GBCC.  대한민국
  • (2016)  Impact of young age on recurrence and mortality after surgery in breast cancer:15 years active surveillance.  San Antonio Breast Cancer Symposium.  미국
  • (2016)  Tamoxifen resistance:EGFR expression in hormone receptor-positive and HER2 negative breast cancer.  San Antonio Breast Cancer Symposium.  미국